You Think The U.S. Has Vaccine Issues? 130 Countries Haven't Even Started Vaccinating
3 years, 10 months ago

You Think The U.S. Has Vaccine Issues? 130 Countries Haven't Even Started Vaccinating

NPR  

You Think The U.S. Has Vaccine Issues? 130 Countries Haven't Even Started Vaccinating Enlarge this image toggle caption Michael Dantas/AFP via Getty Images Michael Dantas/AFP via Getty Images In some countries, citizens are grumbling about the inefficient rollout of COVID-19 vaccines. "I think that there is a lot of concern," says Sergio Litewka, a professor of surgery and ethics at the University of Miami, about whether countries in Latin America are going to be able to get enough effective vaccine to inoculate their populations. "Vaccine manufacturers and others are currently evaluating the vaccines to see how effective they are against these new variants," Swaminathan says. Pitta says countries are so desperate to get vaccine that they're willing to accept claims of safety and efficacy about the products even without seeing data to back up those claims.

Russia South Africa Latin America Colombia Vaccines Countries Covid Sponsor Message Vaccine Effective Doses Astrazeneca Sputnik Pitta 130 Countries  think  astrazeneca  argentina  vaccine  130  doses  effective  issues  product  havent  variants  started  vaccines  countries  sputnik  vaccinating

History of this topic

A twice-yearly shot could help end AIDS. But will it get to everyone who needs it?
1 month, 1 week ago

A twice-yearly shot could help end AIDS. But will it get to everyone who needs it?

The Independent  

For free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Sign up to our free breaking news emails SIGN UP I would like to be emailed about offers, events and updates from The Independent. In a statement, Gilead said it has “an ongoing …

A twice-yearly shot could help end AIDS. But will it get to everyone who needs it?
1 month, 1 week ago

A twice-yearly shot could help end AIDS. But will it get to everyone who needs it?

Live Mint  

MEXICO CITY — It’s been called the closest the world has ever come to a vaccine against the AIDS virus. In a statement, Gilead said it has “an ongoing commitment to helping enable access to HIV prevention and treatment options where the need is the greatest.” Among the 120 countries eligible for generic version are 18 mostly African countries that …

A twice-yearly shot could help end AIDS. But will it get to everyone who needs it?
Trending News
1 month, 1 week ago

A twice-yearly shot could help end AIDS. But will it get to everyone who needs it?

Associated Press  

MEXICO CITY — It’s been called the closest the world has ever come to a vaccine against the AIDS virus. In a statement, Gilead said it has “an ongoing commitment to helping enable access to HIV prevention and treatment options where the need is the greatest.” Among the 120 countries eligible for generic version are 18 mostly African countries that …

Why Americans are opting out of getting a COVID booster shot
1 month, 2 weeks ago

Why Americans are opting out of getting a COVID booster shot

Daily Mail  

A recent survey reveals that a significant number of Americans are unlikely to get a COVID-19 booster vaccine this season. Conducted by the Pew Research Center between October 21 and 27, the survey of 9,593 U.S. adults found that 60% of respondents said they would 'probably not' get an updated vaccine. A full 81% of Republicans said they probably wouldn't …

BORIS JOHNSON: Why I considered invading Holland with a dramatic canal raid to snatch our five million stolen vaccines back from Brussels' clutches
3 months, 1 week ago

BORIS JOHNSON: Why I considered invading Holland with a dramatic canal raid to snatch our five million stolen vaccines back from Brussels' clutches

Daily Mail  

Britain's top brass filed into my office in No 10, bearing with them hundreds of years of collective operational experience, from Afghanistan to Zimbabwe. Boris receives his Covid booster Jab at London's St Thomas' Hospital in December 2021 A nurse holds a phial of the Pfizer BioNTech Covid vaccine at Guy's Hospital in London as the immunisation programme begins in …

Covishield Side Effects: Doctors' Group Urges Govt to Review All Covid Vaccines
7 months, 4 weeks ago

Covishield Side Effects: Doctors' Group Urges Govt to Review All Covid Vaccines

News 18  

In the wake of pharmaceutical giant AstraZeneca admitting in a UK court that its Covid vaccine can cause blood clots in rare cases, a group of doctors on Thursday expressed deep concern over the safety of the Covishield vaccine manufactured by the Serum Institute of India. At a press conference, the doctors, under the banner of the Awaken India Movement, …

AstraZeneca's Covishield Showed Lowest Incidence of Side Effects in India Versus Globally, Says Top Govt Official
8 months ago

AstraZeneca's Covishield Showed Lowest Incidence of Side Effects in India Versus Globally, Says Top Govt Official

News 18  

AstraZeneca’s vaccine has demonstrated the lowest incidence of side effects in India compared to the global average, a top government official involved in the national roll-out of Covid-19 vaccination told News18. “But only around 50 cases witnessed Thrombosis with Thrombocytopenia Syndrome — a rare side effect caused by the jab — of the 180 crore doses administered against 4 to …

After AstraZeneca covid-19 vax recall worldwide, Serum says it stopped manufacturing jabs in Dec 2021
8 months ago

After AstraZeneca covid-19 vax recall worldwide, Serum says it stopped manufacturing jabs in Dec 2021

Live Mint  

New Delhi: The Serum Institute of India on Wednesday said it has stopped making and supplying covid-19 vaccine Covishield after AstraZeneca, the British drugmaker that helped develop the vaccine, announced it too was withdrawing its version of the jab worldwide. The development follows the launch of a class action suit in the UK over allegations that the UK vaccine caused …

AstraZeneca pulls its COVID-19 vaccine from the European market
8 months ago

AstraZeneca pulls its COVID-19 vaccine from the European market

Associated Press  

LONDON — The pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled, according to the EU medicines regulator. In an update on the European Medicines Agency’s website Wednesday, the regulator said that the approval for AstraZeneca’s Vaxzevria had been withdrawn “at the request of the marketing authorization holder.” AstraZeneca’s COVID-19 vaccine was first given …

AstraZeneca withdraws COVID-19 vaccine citing a decline in demand
8 months ago

AstraZeneca withdraws COVID-19 vaccine citing a decline in demand

ABC  

In short: Pharmaceutical company AstraZeneca has started a global withdrawal of its COVID-19 vaccine, Vaxzevria, which has not been available in Australia since March 2023. Pharmaceutical company AstraZeneca has started a global withdrawal of its COVID-19 vaccine, Vaxzevria, which has not been available in Australia since March 2023. AstraZeneca has initiated the worldwide withdrawal of its COVID-19 vaccine due to …

AstraZeneca removes its Covid vaccine worldwide after rare and dangerous side effect linked to 80 deaths in Britain was admitted in court papers
8 months ago

AstraZeneca removes its Covid vaccine worldwide after rare and dangerous side effect linked to 80 deaths in Britain was admitted in court papers

Daily Mail  

AstraZeneca is removing its Covid vaccine worldwide, months after the pharmaceutical giant admitted that it can cause a rare and dangerous side effect. The vaccine, once heralded as a 'triumph for British science', has come under intense scrutiny in recent months for a very rare side effect causing blood clots and low blood platelet counts. The AstraZeneca jab was the …

COVID-19 vaccines: Much ado about known unknowns
8 months ago

COVID-19 vaccines: Much ado about known unknowns

The Hindu  

There are things we know that we don’t know. This risk was identified and flagged back in 2021; packaging was modified to insert information associated with the side effects; even the WHO wrote about it first in May 2021 and then in 2023.Read Bindu Shajan Perapaddan’s report on the rare vaccine side-effect is “no secret” and they are “well aware …

AstraZeneca reaffirms Covid vaccine safety amid rare side effect concerns
8 months, 1 week ago

AstraZeneca reaffirms Covid vaccine safety amid rare side effect concerns

India TV News  

In response to recent concerns regarding potential rare side effects associated with the AstraZeneca-Oxford COVID-19 vaccine, the pharmaceutical company has underscored its unwavering commitment to patient safety while affirming the vaccine's overall safety profile. This comes in the wake of a recent admission by AstraZeneca, the pharmaceutical company, that its Covid vaccine Covishield and Vaxzevria "can, in very rare cases, …

EU countries destroyed €4 billion worth of Covid-19 vaccines, reveals research
1 year ago

EU countries destroyed €4 billion worth of Covid-19 vaccines, reveals research

Firstpost  

Governments, including the EU’s second-most populous country France, have been reluctant to reveal the scale of the waste, but it is certain that most EU nations have resorted to wasting doses of the Covid-19 vaccine, once a much sought after commodity Nearly 215 million doses of Covid-19 vaccines purchased by EU countries at the height of the pandemic have since …

Mexico develops own COVID-19 vaccine, 2 years late
1 year, 8 months ago

Mexico develops own COVID-19 vaccine, 2 years late

Associated Press  

MEXICO CITY — Mexican officials celebrated Wednesday the announcement that the country finally developed its own COVID-19 vaccine, more than two years after inoculations from the U.S., Europe and China were rolled out. María Elena Álvarez-Buylla, the head of Mexico’s government commission for science and technology, said the new vaccine would be approved for use as a booster shot. Dr. …

Why millions of kids aren't getting their routine vaccinations
1 year, 8 months ago

Why millions of kids aren't getting their routine vaccinations

NPR  

Why millions of kids aren't getting their routine vaccinations Enlarge this image toggle caption Bachchan Kumar/Hindustan Times via Getty Images Bachchan Kumar/Hindustan Times via Getty Images A new report released by UNICEF finds that 67 million children across the world missed out on either some or all routine vaccinations between 2019 and 2021, and 48 million children didn't receive a …

As COVID-19 spikes in California, booster shots could make all the difference
2 years, 1 month ago

As COVID-19 spikes in California, booster shots could make all the difference

LA Times  

With coronavirus cases and hospitalizations rising in Los Angeles County, officials are voicing new confidence in the effectiveness of the updated COVID-19 booster shot. New data has found that the updated COVID-19 vaccines offer “significant additional protection” against symptomatic infection in people who were previously vaccinated or boosted with the older formula. “We have seen very low uptake of the …

Explained | Can vaccine distribution be made fairer?
2 years, 1 month ago

Explained | Can vaccine distribution be made fairer?

The Hindu  

The story so far: The Global Dashboard for Vaccine Equity, a joint effort by the United Nations Development Programme, the World Health Organization and the University of Oxford with cooperation across the UN system, has put out recent data that justifies the vexatious core of the vaccine distribution programme: Only one in four people has been vaccinated with at least …

COVID vaccination rates have dropped 50% in Africa, WHO says
2 years, 2 months ago

COVID vaccination rates have dropped 50% in Africa, WHO says

LA Times  

The number of COVID-19 vaccine doses given in Africa has dropped by more than 50% over the last three months, the World Health Organization said Thursday, even though less than a quarter of all Africans have been vaccinated. Despite increased availability of vaccines on the continent, Africa still lags far behind the global average, with only 24% of the population …

AstraZeneca Nasal Spray Vaccine for Covid-19 Suffers Setback in Early Trial
2 years, 2 months ago

AstraZeneca Nasal Spray Vaccine for Covid-19 Suffers Setback in Early Trial

News 18  

In a major setback, AstraZeneca and the University of Oxford’s joint trial for the nasal-spray version of the Nonreplicating viral vector vaccine against Covid-19 did not yield desired protection, reported Reuters on Tuesday. The University of Oxford said, “An antibody response in the respiratory mucous membranes was seen in only a minority of participants in the trial, which was in …

Is there enough monkeypox vaccine to go around? Maybe yes, more likely no
2 years, 4 months ago

Is there enough monkeypox vaccine to go around? Maybe yes, more likely no

NPR  

Is there enough monkeypox vaccine to go around? 2) Supply is also limited In an email, a spokesperson for Bavarian Nordic told NPR that the company has the capacity to produce 30 to 40 million doses of JYNNEOS annually. "At least from what's known about Bavarian Nordic's deliveries, they are significantly lower than we would expect" if the company really …

How India Pursued Covid-19 Vaccine Diplomacy Amid Vaccine Nationalism By Rich Nations
2 years, 4 months ago

How India Pursued Covid-19 Vaccine Diplomacy Amid Vaccine Nationalism By Rich Nations

ABP News  

The last 30 months have seen the world getting ravaged by Covid-19. When rich nations of the Global North were stockpiling and hoarding Covid-19 vaccines, many times more than their population, India not only spearheaded one of the largest vaccine drives within the country but also shared the vaccine doses with low- and middle-income countries worldwide. India supplied 23.9 crore …

COVID-19: Over 7.20 crore unutilized vaccine doses available with States, Union Territories says health ministry
2 years, 5 months ago

COVID-19: Over 7.20 crore unutilized vaccine doses available with States, Union Territories says health ministry

Firstpost  

The vaccination drive has been ramped up through the availability of more vaccines, advance visibility of vaccine availability to States and UTs for enabling better planning by them, and streamlining the vaccine supply chain New Delhi: The Ministry of Health and Family Welfare on Sunday informed that more than 7.20 crore balance and unutilized COVID-19 vaccine doses are still available …

In race for monkeypox vaccines, experts see repeat of COVID-19
2 years, 5 months ago

In race for monkeypox vaccines, experts see repeat of COVID-19

The Hindu  

Moves by rich countries to buy large quantities of monkeypox vaccine, while declining to share doses with Africa, could leave millions of people unprotected against a more dangerous version of the disease and risk continued spillovers of the virus into humans, public health officials are warning. Yet while monkeypox is much harder to spread than COVID-19, experts warn that if …

Monkeypox: Rich countries stocking vaccines and declining to share with Africa could leave millions unprotected
2 years, 5 months ago

Monkeypox: Rich countries stocking vaccines and declining to share with Africa could leave millions unprotected

Firstpost  

Experts fear that the mistakes which were committed during the COVID-19 pandemic are already being repeated London: Moves by rich countries to buy large quantities of monkeypox vaccine, while declining to share doses with Africa, could leave millions of people unprotected against a more dangerous version of the disease and risk continued spillovers of the virus into humans, public health …

Will Americans have the right COVID-19 vaccine this fall? Maybe
2 years, 5 months ago

Will Americans have the right COVID-19 vaccine this fall? Maybe

LA Times  

A man walks underneath the marquee of the Alex Theatre in Glendale. Determining which recipe should go into those doses to induce optimal protection — the vaccine’s “composition” — is an exercise in educated guesswork. Getting a timely and accurate fix on all this “is truly a challenge, and it is science at its hardest,” Dr. Peter Marks, the U.S. …

WHO: COVID-19 cases rising nearly everywhere in the world
2 years, 6 months ago

WHO: COVID-19 cases rising nearly everywhere in the world

Associated Press  

GENEVA — The number of new coronavirus cases rose by 18% in the last week, with more than 4.1 million cases reported globally, according to the World Health Organization. The biggest weekly rise in new COVID-19 cases was seen in the Middle East, where they increased by 47%, according to the report released late Wednesday. WHO Director-General Tedros Adhanom Ghebreyesus …

COVID-19 changing, not over yet; tough to analyse future emerging variants: WHO
2 years, 6 months ago

COVID-19 changing, not over yet; tough to analyse future emerging variants: WHO

India TV News  

Highlights COVID19, driven by BA.4 and BA.5, cases are on the rise in 110 countries, the WHO said This has caused the overall global cases to increase by 20 per cent, it said Health workers and older people in lower-income countries remain unvaccinated, the WHO expressed COVID-19 pandemic is changing, but is not over yet, the World Health Organisation said …

COVID-19 cases rising nearly everywhere in the world, WHO reports
2 years, 6 months ago

COVID-19 cases rising nearly everywhere in the world, WHO reports

LA Times  

Adm. Rachel Levine, the Department of Health and Human Services assistant secretary for health, watches a pediatric vaccination in Miami on June 28. The worldwide number of new coronavirus cases rose by 18% in the last week, with more than 4.1 million cases reported globally, according to the World Health Organization. The United Nations health agency said in its latest …

WHO to share vaccines to stop monkeypox amid inequity fears
2 years, 6 months ago

WHO to share vaccines to stop monkeypox amid inequity fears

Associated Press  

LONDON — The World Health Organization said it’s creating a new vaccine-sharing mechanism to stop the outbreak of monkeypox in more than 30 countries beyond Africa. WHO’s Europe director, Dr. Hans Kluge, said Wednesday he was concerned by the scramble by some rich countries to buy more vaccines without talk of buying supplies for Africa. Kluge urged governments “to approach …

WHO to share vaccines to stop monkeypox amid inequity fears
2 years, 6 months ago

WHO to share vaccines to stop monkeypox amid inequity fears

LA Times  

These mature, oval-shaped monkeypox virions, left, and immature, spherical virions, right, were obtained from a person infected during a 2003 outbreak. The World Health Organization said it’s creating a new vaccine-sharing mechanism to stop the outbreak of monkeypox in more than 30 countries beyond Africa. The WHO has described the outbreak as “unusual” and said the virus’ continuing spread was …

Novavax hopes its COVID shot wins over FDA, vaccine holdouts
2 years, 7 months ago

Novavax hopes its COVID shot wins over FDA, vaccine holdouts

Associated Press  

— Americans may soon get a new COVID-19 vaccine option -- shots made with a more tried-and-true technology than today’s versions. “What I’ve seen of the Novavax data so far is it’s a really impressive protein vaccine,” said University of Pennsylvania immunologist E. John Wherry. Novavax, a small biotech company, created the vaccine in its research lab, but the Serum …

Q&A: Novavax hopes its COVID shot wins over FDA, vaccine holdouts
2 years, 7 months ago

Q&A: Novavax hopes its COVID shot wins over FDA, vaccine holdouts

LA Times  

Americans may soon get a new COVID-19 vaccine option — shots made with a more tried-and-true technology than today’s versions. “What I’ve seen of the Novavax data so far is it’s a really impressive protein vaccine,” said University of Pennsylvania immunologist E. John Wherry. Novavax, a small biotech company, created the vaccine in its research lab, but the Serum Institute …

Pfizer to offer low-cost medicines, vaccines to poor nations
2 years, 7 months ago

Pfizer to offer low-cost medicines, vaccines to poor nations

Associated Press  

Pfizer said Wednesday that it will provide nearly two dozen products, including its top-selling COVID-19 vaccine and treatment, at not-for-profit prices in some of the world’s poorest countries. The drugmaker announced the program at the World Economic Forum’s annual gathering in Davos, Switzerland, and said it was aimed at improving health equity in 45 lower-income countries. “What we discovered through …

Pfizer to offer low-cost drugs to 45 lower-income nations
2 years, 7 months ago

Pfizer to offer low-cost drugs to 45 lower-income nations

Al Jazeera  

US pharmaceutical giant says it will sell patented drugs on a not-for-profit basis to world’s poorest countries. US pharmaceutical giant Pfizer has said it would sell its patented drugs on a not-for-profit basis to the world’s poorest countries, as part of a new initiative announced at the World Economic Forum in Davos. “An Accord for a Healthier World” focuses on …

With old-school technology, can Novavax win over COVID vaccine skeptics?
2 years, 7 months ago

With old-school technology, can Novavax win over COVID vaccine skeptics?

LA Times  

A vial of the Novavax COVID-19 vaccine is ready for use in a Phase 3 clinical trial in London. Some people “may prefer tried and true technologies” for COVID-19 vaccines, said Dr. Filip Dubovsky, the chief medical officer of Novavax. It’s even possible a single Novavax shot could target multiple coronavirus variants in one shot, although Dubovsky said it makes …

Africa's COVID vaccine production line in jeopardy
2 years, 7 months ago

Africa's COVID vaccine production line in jeopardy

The Hindu  

Trisha shakes her head when asked if she's vaccinated. 'A massive setback for Africa's plans' In the absence of orders or commitments, Aspen is considering the repurposing of two COVID-19 production lines for the manufacture of other products. "The continent would lose its only existing COVID vaccine manufacturing capacity," Nicolaou says. Africa's major public health body, the Africa Centers for …

AstraZeneca Covid Booster Shot Effective Against Severe Disease, UK Study Finds
2 years, 8 months ago

AstraZeneca Covid Booster Shot Effective Against Severe Disease, UK Study Finds

News 18  

London: The third dose of AstraZeneca COVID-19 vaccine is effective against symptomatic disease and hospitalisation, offering protection comparable to a booster shot of the Pfizer preventive, according to a study conducted in the UK. The results show that after 25 or more weeks since primary vaccination with AstraZeneca, vaccine effectiveness against symptomatic disease post Omicron infection was 8.0 per cent …

UN official urges acceleration in coronavirus vaccinations
2 years, 8 months ago

UN official urges acceleration in coronavirus vaccinations

Associated Press  

UNITED NATIONS — The U.N. official spearheading global vaccination efforts against the coronavirus said Monday the number of countries where 10% or less of the population has been vaccinated dropped from 34 to 18 since January and called for accelerated progress to end the pandemic. Assistant Secretary-General Ted Chaiban told the U.N. Security Council that with over 6 million lives …

Column: While we line up for a fourth shot, the world’s poor haven’t gotten their first
2 years, 9 months ago

Column: While we line up for a fourth shot, the world’s poor haven’t gotten their first

LA Times  

Go ahead — line up for your second booster shot, Americans. The outrageous truth is that two years into the pandemic that has killed 6 million people worldwide, 65% of Americans have received two vaccine shots and are considered “fully vaccinated.” But only 14.5% of people in low-income countries have received even a single dose, according to data compiled by …

Rich countries getting new COVID vaccine before poorer ones despite U.N.-backed initiative
2 years, 9 months ago

Rich countries getting new COVID vaccine before poorer ones despite U.N.-backed initiative

LA Times  

A worker moves boxes carrying Novavax’s COVID-19 vaccine at SK Bioscience Co. in Andong, South Korea, on Feb. 9. Novavax, the company behind a COVID-19 vaccine touted as a key tool for the developing world, will miss a target for giving doses to a U.N.-backed effort to supply shots to poorer countries. The company behind a COVID-19 vaccine touted as …

Rich Countries Getting New COVID Vaccine Before Poorer Ones
2 years, 9 months ago

Rich Countries Getting New COVID Vaccine Before Poorer Ones

Huff Post  

FILE - A worker moves boxes carrying Novavax's COVID-19 vaccine at SK Bioscience Co. in Andong, South Korea, on Feb. 9, 2022. via Associated Press NEW DELHI — The company behind a COVID-19 vaccine touted as a key tool for the developing world has sent tens of millions of doses to wealthy nations but provided none yet to the U.N.-backed …

Rich countries getting new COVID vaccine before poorer ones
2 years, 9 months ago

Rich countries getting new COVID vaccine before poorer ones

Associated Press  

NEW DELHI — The company behind a COVID-19 vaccine touted as a key tool for the developing world has sent tens of millions of doses to wealthy nations but provided none yet to the U.N.-backed effort to supply poorer countries, a sign that inequity persists in the global response to the pandemic. The company, Novavax, got $388 million from one …

Rich countries getting new Novavax COVID-19 vaccine before poorer ones
2 years, 9 months ago

Rich countries getting new Novavax COVID-19 vaccine before poorer ones

LA Times  

The company behind a COVID-19 vaccine touted as a key tool for the developing world has sent tens of millions of doses to wealthy nations but provided none yet to the United Nations-backed effort to supply poorer countries, a sign that inequity persists in the global response to the pandemic. The investment guaranteed COVAX the “right of first refusal” to …

Op-Ed: What will it take to make a universal COVID vaccine?
2 years, 9 months ago

Op-Ed: What will it take to make a universal COVID vaccine?

LA Times  

As California emerges from Omicron, other places are again in lockdown or facing record caseloads after trying and failing to avoid the variant. Since this protein is so prone to mutation, making it harder for the body to recognize in future variants, a more universal vaccine must target parts of the virus that are shared among several viruses in the …

AstraZeneca set to abandon push for US vaccine approval
2 years, 9 months ago

AstraZeneca set to abandon push for US vaccine approval

The Telegraph  

AstraZeneca is braced to abandon efforts to get its Covid vaccine approved in the US if it is simply "banging its head against a brick wall indefinitely" with regulators. Speaking to the Financial Times, he said: “If we don’t end up submitting it for a BLA, I don’t think it will have an impact around the world.” The company has …

Why are COVID vaccination rates still low in some countries?
2 years, 10 months ago

Why are COVID vaccination rates still low in some countries?

Associated Press  

Why are COVID-19 vaccination rates still low in some countries? Other countries with extremely low vaccination rates include Yemen, Syria, Haiti and Papua New Guinea. “The main problem among countries with low vaccination rates is poor infrastructure to distribute shots,” says Dina Borzekowski, director of the Global Health Initiative at the University of Maryland. “What is absent are best practices …

COVID: New protein-based vaccine up for approval
2 years, 10 months ago

COVID: New protein-based vaccine up for approval

The Hindu  

Sanofi and GlaxoSmithKline are seeking E.U. and U.S. regulatory approval of their protein-based COVID-19 vaccine, which proved 100 per cent effective at preventing severe illness in phase three clinical trials, the duo announced on Wednesday. Official trial results are yet to be published, but the companies reported that in phase three testing, two doses of the vaccine showed 100 per …

Critical AstraZeneca views ‘probably killed hundreds of thousands’ – scientist
2 years, 11 months ago

Critical AstraZeneca views ‘probably killed hundreds of thousands’ – scientist

The Independent  

Sign up for our free Health Check email to receive exclusive analysis on the week in health Get our free Health Check email Please enter a valid email address Please enter a valid email address SIGN UP I would like to be emailed about offers, events and updates from The Independent. Please try again later {{ /verifyErrors }} An Oxford …

Africa CDC director urges youths to boost COVID vaccinations
2 years, 11 months ago

Africa CDC director urges youths to boost COVID vaccinations

Associated Press  

ABUJA, Nigeria — Africa’s top health official is launching a campaign to enlist young people to encourage vaccinations, as just 11.3% of the continent’s 1.3 billion people are vaccinated against COVID-19. Youths will be encouraged “to play an active role” in ramping up inoculations across the continent where the vaccination rate is far below other regions in the world, Africa …

Discover Related